THE Et.-myc TRANSGENIC MOUSE A Model for High-incidence Spontaneous Lymphoma and Leukemia of Early B Cells
نویسندگان
چکیده
Translocation of the c-myc protooncogene into or near one of the Ig loci is found in almost every case of Burkitt's B cell lymphoma in man and experimentally induced plasma cell tumor in the mouse (reviewed in references 1, 2) . This accidental rearrangement of the cellular genome appears to free the c-myc gene from its normal susceptibility to negative regulation and to render it constitutively active in cells that express Ig genes (reviewed in references 1-4) . The contribution of the rearranged gene to the neoplastic phenotype may stem from the ability ofthe myc polypeptide to drive cellular proliferation, perhaps by promoting DNA replication (5, 6) . While its biochemical function is not yet defined, c-myc expression normally correlates closely with cell-cycle activity in a broad range of cell types, increasing greatly when resting cells are mitogenically stimulated and declining when they cease to proliferate (3, 4, 7) . The effects of altered oncogenes on cells in their natural environment can be assessed through the use of transgenic mice (8, 9) . A transgenic strain is initiated by inserting a gene into the mouse genome and is perpetuated thereafter by normal breeding . By this means, a c-myc gene coupled to regulatory sequences from the mousemammary tumor virus was shown to cause mammary carcinomas, and sometimes other tumors, after a substantial latent period (10, 11). To mimic the translocated myc genes found in lymphoid tumors, we introduced into mice a DNA sequence, designated EA-myc, isolated from a mouse plasmacytoma in which a normal myc gene had become coupled to the Ig heavy chain enhancer (12) . In the resultant transgenic mice, the El-myc transgene appears to be expressed exclusively in B-lymphoid cells (13) and causes them to proliferate more than normal (14) . Starting before birth, the pre-B cell population expands progressively up to about five times its normal size, while B cells are somewhat reduced in number despite their increased cell-cycle activity (14) . The immune
منابع مشابه
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.
Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and immune suppressive cancers. We aimed to boost antitumor immunity in B-cell lymphoma by developing a tumor cell vaccine incorporating α-galactosylceramide (α-GalCer) that targets the immune adjuvant properties of NKT cells. In the Eμ-myc t...
متن کاملStrain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice
The transgenic mice were produced by injecting eggs of B6 and C3H/HeJ mice with the human E mu-myc gene. Preferential development of B lymphomas was observed in the B6 transgenic mice, whereas the C3H/HeJ transgenic mice developed mostly T lymphomas. The phenotypic activation of B lineage cells but not of T lineage cells was detected in the prelymphomatous transgenic mice of both strains. The t...
متن کاملEarly generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression
In mice, generation of autoreactive CD5+ B cells occurs as a consequence of BCR signaling induced by (self)-ligand exposure from fetal/neonatal B-1 B cell development. A fraction of these cells self-renew and persist as a minor B1 B cell subset throughout life. Here, we show that transfer of early generated B1 B cells from Eμ-TCL1 transgenic mice resulted in chronic lymphocytic leukemia (CLL) w...
متن کاملCDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
The G1 kinase CDK4 is amplified or overexpressed in some human tumors and promotes tumorigenesis by inhibiting known tumor suppressors. Here, we report that CDK4 deficiency markedly accelerated lymphoma development in the Eμ-Myc transgenic mouse model of B lymphoma and that silencing or loss of CDK4 augmented the tumorigenic potential of Myc-driven mouse and human B cell lymphoma in transplant ...
متن کاملId2 is dispensable for myc-induced lymphomagenesis.
The Emu-Myc transgenic mouse appears to be an accurate model of human Burkitt's lymphoma that bears MYC/Immunoglobulin gene translocations. Id2, a negative regulator of basic helix-loop-helix transcription factors, has also been proposed as a Myc target gene that drives the proliferative response of Myc by binding to and overriding the checkpoint functions of the retinoblastoma tumor suppressor...
متن کامل